HEADER TRANSFERASE 20-MAY-21 7OLV TITLE MERTK KINASE DOMAIN WITH TYPE 1.5 INHIBITOR CONTAINING A DI-METHYL, TITLE 2 CYANO PYRAZOLE GROUP COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (571-864); COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER,RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MERTK, MER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TYROSINE KINASE INHIBITOR, STRUCTURE-BASED DRUG DESIGN, TYPE 1.5 KEYWDS 2 INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.PFLUG,M.SCHIMPL,W.MCCOULL,J.W.M.NISSINK,J.WINTER-HOLT REVDAT 4 31-JAN-24 7OLV 1 REMARK REVDAT 3 06-OCT-21 7OLV 1 JRNL REVDAT 2 29-SEP-21 7OLV 1 JRNL REVDAT 1 15-SEP-21 7OLV 0 JRNL AUTH W.MCCOULL,S.BOYD,M.R.BROWN,M.COEN,O.COLLINGWOOD,N.L.DAVIES, JRNL AUTH 2 A.DOHERTY,G.FAIRLEY,K.GOLDBERG,E.HARDAKER,G.HE,E.J.HENNESSY, JRNL AUTH 3 P.HOPCROFT,G.HODGSON,A.JACKSON,X.JIANG,A.KARMOKAR,A.L.LAINE, JRNL AUTH 4 N.LINDSAY,Y.MAO,R.MARKANDU,L.MCMURRAY,N.MCLEAN,L.MOONEY, JRNL AUTH 5 H.MUSGROVE,J.W.M.NISSINK,A.PFLUG,V.P.REDDY,P.B.RAWLINS, JRNL AUTH 6 E.RIVERS,M.SCHIMPL,G.F.SMITH,S.TENTARELLI,J.TRAVERS, JRNL AUTH 7 R.I.TROUP,J.WALTON,C.WANG,S.WILKINSON,B.WILLIAMSON, JRNL AUTH 8 J.WINTER-HOLT,D.YANG,Y.ZHENG,Q.ZHU,P.D.SMITH JRNL TITL OPTIMIZATION OF AN IMIDAZO[1,2- A ]PYRIDINE SERIES TO AFFORD JRNL TITL 2 HIGHLY SELECTIVE TYPE I1/2 DUAL MER/AXL KINASE INHIBITORS JRNL TITL 3 WITH IN VIVO EFFICACY. JRNL REF J.MED.CHEM. V. 64 13524 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34478292 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00920 REMARK 2 REMARK 2 RESOLUTION. 2.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 3 NUMBER OF REFLECTIONS : 11156 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 586 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.13 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.19 REMARK 3 REFLECTION IN BIN (WORKING SET) : 62 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 5.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE SET COUNT : 6 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2137 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.63000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.500 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.271 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.046 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2221 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2111 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3010 ; 1.145 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4841 ; 0.871 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 270 ; 5.389 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;33.128 ;23.478 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 380 ;13.854 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;22.028 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 337 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2455 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 492 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7OLV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1292115992. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980073 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11729 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 65.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 56.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.65000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3BRB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.5, 4.3 M NACL, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.69350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.69350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.68950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.27050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.68950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.27050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.69350 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.68950 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.27050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.69350 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.68950 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 46.27050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A 903 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 622 REMARK 465 LEU A 623 REMARK 465 ASP A 624 REMARK 465 ASN A 625 REMARK 465 LEU A 744 REMARK 465 SER A 745 REMARK 465 LYS A 746 REMARK 465 LYS A 747 REMARK 465 ILE A 748 REMARK 465 TYR A 749 REMARK 465 SER A 750 REMARK 465 GLY A 751 REMARK 465 ASP A 752 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ARG A 758 REMARK 465 ILE A 759 REMARK 465 ALA A 760 REMARK 465 LYS A 761 REMARK 465 MET A 762 REMARK 465 ASP A 863 REMARK 465 VAL A 864 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 571 CG CD OE1 OE2 REMARK 470 GLU A 572 CG CD OE1 OE2 REMARK 470 GLU A 578 CG CD OE1 OE2 REMARK 470 GLU A 597 CG CD OE1 OE2 REMARK 470 PHE A 598 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 609 CG CD OE1 OE2 REMARK 470 GLU A 630 CG CD OE1 OE2 REMARK 470 ARG A 651 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 662 CG CD OE1 NE2 REMARK 470 LYS A 666 CG CD CE NZ REMARK 470 ARG A 693 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 774 CG OD1 OD2 REMARK 470 ARG A 775 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 694 122.75 -35.27 REMARK 500 ASP A 723 45.00 -166.82 REMARK 500 MET A 735 19.06 59.80 REMARK 500 ALA A 773 -76.86 -73.76 REMARK 500 TYR A 801 63.45 60.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VK2 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 906 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7OLS RELATED DB: PDB REMARK 900 PDB ENTRY FOR THE SAME CITATION DBREF 7OLV A 571 864 UNP Q12866 MERTK_HUMAN 571 864 SEQADV 7OLV GLY A 567 UNP Q12866 EXPRESSION TAG SEQADV 7OLV SER A 568 UNP Q12866 EXPRESSION TAG SEQADV 7OLV HIS A 569 UNP Q12866 EXPRESSION TAG SEQADV 7OLV MET A 570 UNP Q12866 EXPRESSION TAG SEQADV 7OLV ARG A 591 UNP Q12866 LYS 591 ENGINEERED MUTATION SEQADV 7OLV ARG A 693 UNP Q12866 LYS 693 ENGINEERED MUTATION SEQADV 7OLV ARG A 702 UNP Q12866 LYS 702 ENGINEERED MUTATION SEQADV 7OLV ARG A 856 UNP Q12866 LYS 856 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER HIS MET GLU GLU LEU GLN ASN LYS LEU GLU ASP SEQRES 2 A 298 VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY ARG ILE SEQRES 3 A 298 LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU GLY ASN SEQRES 4 A 298 LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL ALA VAL SEQRES 5 A 298 LYS THR MET LYS LEU ASP ASN SER SER GLN ARG GLU ILE SEQRES 6 A 298 GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS ASP PHE SEQRES 7 A 298 SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL CYS ILE SEQRES 8 A 298 GLU MET SER SER GLN GLY ILE PRO LYS PRO MET VAL ILE SEQRES 9 A 298 LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR TYR LEU SEQRES 10 A 298 LEU TYR SER ARG LEU GLU THR GLY PRO ARG HIS ILE PRO SEQRES 11 A 298 LEU GLN THR LEU LEU ARG PHE MET VAL ASP ILE ALA LEU SEQRES 12 A 298 GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU HIS ARG SEQRES 13 A 298 ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP ASP MET SEQRES 14 A 298 THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS LYS ILE SEQRES 15 A 298 TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE ALA LYS SEQRES 16 A 298 MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU ALA ASP SEQRES 17 A 298 ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA PHE GLY SEQRES 18 A 298 VAL THR MET TRP GLU ILE ALA THR ARG GLY MET THR PRO SEQRES 19 A 298 TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP TYR LEU SEQRES 20 A 298 LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP CYS LEU SEQRES 21 A 298 ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP ARG THR SEQRES 22 A 298 ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU ARG LEU SEQRES 23 A 298 GLN LEU GLU ARG LEU LEU GLU SER LEU PRO ASP VAL HET VK2 A 901 33 HET CL A 902 1 HET CL A 903 1 HET CL A 904 1 HET CL A 905 1 HET DMS A 906 4 HETNAM VK2 4-[4-[5-[IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYL(METHYL) HETNAM 2 VK2 AMINO]-1,3,4-OXADIAZOL-2-YL]-3-METHYL-PHENYL]-2,5- HETNAM 3 VK2 DIMETHYL-PYRAZOLE-3-CARBONITRILE HETNAM CL CHLORIDE ION HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 VK2 C24 H22 N8 O FORMUL 3 CL 4(CL 1-) FORMUL 7 DMS C2 H6 O S FORMUL 8 HOH *31(H2 O) HELIX 1 AA1 GLY A 567 VAL A 581 1 15 HELIX 2 AA2 ASP A 583 ASN A 585 5 3 HELIX 3 AA3 SER A 627 ASP A 643 1 17 HELIX 4 AA4 ASP A 678 SER A 686 1 9 HELIX 5 AA5 PRO A 696 ARG A 717 1 22 HELIX 6 AA6 ALA A 725 ARG A 727 5 3 HELIX 7 AA7 PRO A 763 ILE A 767 5 5 HELIX 8 AA8 ALA A 768 ASP A 774 1 7 HELIX 9 AA9 THR A 778 THR A 795 1 18 HELIX 10 AB1 GLN A 805 HIS A 807 5 3 HELIX 11 AB2 GLU A 808 HIS A 815 1 8 HELIX 12 AB3 LEU A 826 CYS A 836 1 11 HELIX 13 AB4 ASP A 840 ARG A 844 5 5 HELIX 14 AB5 THR A 846 LEU A 861 1 16 SHEET 1 AA1 5 LEU A 587 GLU A 595 0 SHEET 2 AA1 5 SER A 600 LYS A 607 -1 O GLU A 603 N GLY A 590 SHEET 3 AA1 5 SER A 613 THR A 620 -1 O VAL A 618 N MET A 602 SHEET 4 AA1 5 PRO A 665 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 AA1 5 GLY A 654 MET A 659 -1 N CYS A 656 O MET A 668 SHEET 1 AA2 2 CYS A 729 LEU A 731 0 SHEET 2 AA2 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 SITE 1 AC1 15 ALA A 617 PHE A 634 GLU A 637 ALA A 638 SITE 2 AC1 15 MET A 641 LEU A 652 VAL A 655 LEU A 671 SITE 3 AC1 15 PRO A 672 PHE A 673 MET A 674 MET A 730 SITE 4 AC1 15 ALA A 740 ASP A 741 PHE A 742 SITE 1 AC2 3 PRO A 802 LYS A 820 HOH A1009 SITE 1 AC3 1 ARG A 687 SITE 1 AC4 3 ARG A 651 MET A 674 ARG A 732 SITE 1 AC5 1 ASP A 733 SITE 1 AC6 3 HIS A 817 ARG A 818 TYR A 830 CRYST1 91.379 92.541 71.387 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010943 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014008 0.00000